FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds described by a structural formula wherein: R1 is chosen from a group including R9-phenyl, and R2 is chosen from a group including H and (C1-C6)-alkyl; R3 is chosen from a group including (C1-C6)-alkyl, (C1-C6)-alkoxy-(C1-C6)-alkyl- and R9-(C6-C10)-aryl; R4, R5, R6 and R7 are independently chosen from a group including H and (C1-C6)-alkyl; R8 is chosen from a group including и ; R9 means 1, 2 or 3 substitutes independently chosen from a group, including H, halogen and -CF3; R10 is chosen from a group including H and (C1-C6)-alkyl; R11 is (C3-C10)-cycloalkyl-S (O2)-; R15 and R16 are independently (C1-C6)-alkyl; R17 is R20O-; R20 is chosen from a group including H, and (C1-C6)-alkyl-(C6-C10)-aryl; Q is N; Z is CH; n is equal to 0; s is equal to 2; and t is equal to 2. Also, the invention concerns a pharmaceutical composition exhibiting properties of a chemokine receptor inhibitor, based on these compounds.
EFFECT: produced are the new compounds and based pharmaceutical composition can find application in medicine for treating human immunodeficiency virus (HIV) infection.
8 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PIPERAZINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USING AS CCR5 ANTAGONISTS | 2000 |
|
RU2299206C9 |
DERIVATIVES OF PIPERIDINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2002 |
|
RU2316553C2 |
ANALOGUES OF BENZOQUINONE-CONTAINING ANSAMYCINS (VERSIONS), METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION (VERSIONS) AND CANCER TREATMENT METHOD (VERSIONS) | 2004 |
|
RU2484086C9 |
COMBINATIONS OF ACTIVATOR (ACTIVATORS) OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR), AND INHIBITOR (INHIBITORS) OF STEROL ABSORPTION AND TREATMENT OF VASCULAR DISEASES | 2008 |
|
RU2483724C2 |
ANTAGONISTS OF THROMBIN RECEPTOR | 2005 |
|
RU2408594C2 |
SUBSTITUTED BICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION | 1998 |
|
RU2204557C2 |
METHOD OF TREATING DISORDERS ASSOCIATED WITH ALKYLATING AGENT EXPOSURE | 2009 |
|
RU2506083C2 |
DERIVATIVES SHOWING PPAR-RECEPTOR AGONIST ACTIVITY | 2006 |
|
RU2415846C2 |
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS | 2004 |
|
RU2405774C9 |
DERIVATIVES OF BIPIPERIDINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296751C2 |
Authors
Dates
2011-02-10—Published
2006-02-21—Filed